Clusters, classification and epidemiology of interstitial lung diseases: concepts, methods and critical reflections Source: Eur Respir J 2001; 18: 101S-106S Year: 2001
Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180076; 10.1183/16000617.0076-2018 Year: 2018
Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology Source: Eur Respir Rev 2013; 22: 117-123 Year: 2013
Rare lung diseases in children: challenges for diagnosis and treatment Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021
Interstitial lung diseases in infants and children Source: Eur Respir J 2008; 31: 658-666 Year: 2008
Interstital lung diseases: update 2005 Source: Annual Congress 2005 - Clinical year in review Year: 2005
Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases Source: Virtual Congress 2021 – Posters in paediatric bronchology Year: 2021
Delay in diagnosis of interstitial lung diseases (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007
Case for diagnosis Source: Annual Congress 2005 - Paediatric Clinical Grand Round: an interactive session Year: 2005
Interstitial lung diseases: a clinical update Source: Eur Respir J 2001; 18: 1S Year: 2001
Spectrum of interstitial lung diseases (ILDs) and associated prevalence of pulmonary hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021
Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19. Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021
Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001
Interstitial lung disease induced by exogenous agents: factors governing susceptibility Source: Eur Respir J 2001; 18: 30S-42S Year: 2001
Progress in the pathology of diffuse lung disease in infancy: changing concepts and diagnostic challenges Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=21 Year: 2007
The genetics of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019 Year: 2019
SMAD2 mRNA expression is upregulated in fibrosing interstitial lung diseases (ILDs) Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015
Stratified medicine: drugs meet genetics Source: Eur Respir Rev 2013; 22: 53-57 Year: 2013